Bifogade filer
Kurs & Likviditet
Prenumeration
Kalender
2025-02-14 | Bokslutskommuniké 2024 |
2024-11-01 | Kvartalsrapport 2024-Q3 |
2024-08-30 | Kvartalsrapport 2024-Q2 |
2024-05-31 | Ordinarie utdelning IZAFE B 0.00 SEK |
2024-05-30 | Årsstämma 2024 |
2024-04-26 | Kvartalsrapport 2024-Q1 |
2024-02-09 | Bokslutskommuniké 2023 |
2023-12-21 | Extra Bolagsstämma 2024 |
2023-11-17 | Kvartalsrapport 2023-Q3 |
2023-08-25 | Kvartalsrapport 2023-Q2 |
2023-05-12 | Kvartalsrapport 2023-Q1 |
2023-04-06 | Ordinarie utdelning IZAFE B 0.00 SEK |
2023-04-05 | Årsstämma 2023 |
2023-02-03 | Bokslutskommuniké 2022 |
2022-11-07 | Kvartalsrapport 2022-Q3 |
2022-10-05 | Extra Bolagsstämma 2022 |
2022-08-26 | Kvartalsrapport 2022-Q2 |
2022-06-15 | Ordinarie utdelning IZAFE B 0.00 SEK |
2022-06-14 | Årsstämma 2022 |
2022-04-29 | Kvartalsrapport 2022-Q1 |
2022-02-18 | Bokslutskommuniké 2021 |
2021-11-29 | Kvartalsrapport 2021-Q3 |
2021-09-23 | Extra Bolagsstämma 2021 |
2021-08-30 | Kvartalsrapport 2021-Q2 |
2021-06-28 | Årsstämma 2021 |
2021-06-15 | Ordinarie utdelning IZAFE B 0.00 SEK |
2021-04-29 | Kvartalsrapport 2021-Q1 |
2021-02-19 | Bokslutskommuniké 2020 |
2020-11-09 | Kvartalsrapport 2020-Q3 |
2020-08-17 | Kvartalsrapport 2020-Q2 |
2020-06-26 | Ordinarie utdelning IZAFE B 0.00 SEK |
2020-06-25 | Årsstämma 2020 |
2020-05-11 | Kvartalsrapport 2020-Q1 |
2020-02-20 | Bokslutskommuniké 2019 |
2019-05-10 | Ordinarie utdelning IZAFE B 0.00 SEK |
2019-05-06 | Kvartalsrapport 2019-Q1 |
2019-04-10 | Årsstämma 2019 |
2019-02-28 | Bokslutskommuniké 2018 |
2018-12-18 | Extra Bolagsstämma 2018 |
2018-10-24 | Kvartalsrapport 2018-Q3 |
2018-08-29 | Kvartalsrapport 2018-Q2 |
2018-05-24 | Kvartalsrapport 2018-Q1 |
2018-04-12 | Ordinarie utdelning IZAFE B 0.00 SEK |
2018-04-11 | Årsstämma 2018 |
2018-03-22 | Bokslutskommuniké 2017 |
2017-08-29 | Kvartalsrapport 2017-Q2 |
2017-05-09 | Kvartalsrapport 2017-Q1 |
2017-04-26 | Ordinarie utdelning IZAFE B 0.00 SEK |
2017-04-25 | Årsstämma 2017 |
2017-02-24 | Bokslutskommuniké 2016 |
2016-11-16 | Kvartalsrapport 2016-Q3 |
2016-10-19 | Extra Bolagsstämma 2016 |
2016-08-31 | Kvartalsrapport 2016-Q2 |
2016-04-20 | Kvartalsrapport 2016-Q1 |
2016-02-25 | Ordinarie utdelning IZAFE B 0.00 SEK |
2016-02-24 | Årsstämma 2016 |
2016-02-04 | Bokslutskommuniké 2015 |
2015-11-13 | Kvartalsrapport 2015-Q3 |
2015-09-04 | Kvartalsrapport 2015-Q2 |
2015-07-22 | Extra Bolagsstämma 2015 |
2015-05-07 | Ordinarie utdelning IZAFE B 0.00 SEK |
2015-05-06 | Årsstämma 2015 |
2015-04-17 | Kvartalsrapport 2015-Q1 |
2015-02-20 | Bokslutskommuniké 2014 |
2014-12-17 | Extra Bolagsstämma 2014 |
2014-11-28 | Kvartalsrapport 2014-Q3 |
2014-11-14 | Kvartalsrapport 2014-Q3 |
2014-08-29 | Kvartalsrapport 2014-Q2 |
2014-06-12 | Ordinarie utdelning IZAFE B 0.00 SEK |
2014-06-11 | Årsstämma 2014 |
2014-05-16 | Kvartalsrapport 2014-Q1 |
2014-02-21 | Bokslutskommuniké 2013 |
2013-11-15 | Kvartalsrapport 2013-Q3 |
2013-08-28 | Kvartalsrapport 2013-Q2 |
2013-06-17 | Ordinarie utdelning IZAFE B 0.00 SEK |
2013-06-14 | Årsstämma 2013 |
2013-05-17 | Kvartalsrapport 2013-Q1 |
2013-02-22 | Bokslutskommuniké 2012 |
2012-11-30 | Kvartalsrapport 2012-Q3 |
2012-07-31 | Kvartalsrapport 2012-Q2 |
2012-06-20 | Ordinarie utdelning IZAFE B 0.00 SEK |
2012-06-19 | Årsstämma 2012 |
2012-04-20 | Kvartalsrapport 2012-Q1 |
2012-02-21 | Bokslutskommuniké 2011 |
2011-11-04 | Kvartalsrapport 2011-Q3 |
2011-08-12 | Kvartalsrapport 2011-Q2 |
2011-05-06 | Kvartalsrapport 2011-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
iZafe Group (publ.) hereby invites you to a live interview with Pilloxa's CEO Helena Rönnqvist and iZafe Group's CEO Anders Segerström on Wednesday, August 24 at 2 p.m. due to the fact that iZafe has signed a letter of intent with Pilloxa to acquire 100 percent of the shares in Pilloxa.
Read the full news here.
During the interview, all shareholders and stakeholders will get a more in-depth understanding of the rationale behind the acquisition, about Pilloxa as a company and what the acquisition means for the future iZafe Group.
Contacts
Anders Segerström, Chief Executive Officer
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12
iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm
About Us
iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.
The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: info@fnca.se. Further information is available at www.izafe.se/investor-relations/.